Advertisement

Reactions Weekly

, Volume 1748, Issue 1, pp 540–540 | Cite as

Vismodegib

Various toxicities: case report
Case report
  • 12 Downloads

Reference

  1. Meeker J, et al. A novel dosing schedule for vismodegib fails in an attempt to limit side effects and control BCC1. Journal of the American Academy of Dermatology 76 (Suppl. 1): AB18 abstr. 5241, No. 6, Jun 2017. Available from: URL: https://doi.org/10.1016/j.jaad.2017.04.091 [abstract] - USA

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations